HOME / CONTACT US
繁體版 / 简体版
 

MEDIA

Date:2021-04-09

Announcement major subsidiary Cotton Field Organic Co.,Ltd. of 2021 Shareholder's Meeting to approve the release of non-compete restrictions for the directors

 
SEQ_NO
 3
Date of announcement
2021/03/13
Time of announcement
17:53:33
Subject
Announcement major subsidiary Cotton Field
Organic Co.,Ltd. of 2021 Shareholder's Meeting to approve
the release of non-compete restrictions for the directors
Date of events
 2021/04/09
To which item it meets
paragraph 21
Statement
1.Date of the shareholders' meeting resolution:2021/04/09
2.Name and title of the managerial officer with permission
to engage in competitive conduct:
(1)Director:Microbio Co.,Ltd.
(2)Director:Shan Ney, Huang.Juristic-person director of Microbio Co.,Ltd.
(3)Director:Xiang-Chun,Weng.
(4)Director:Chi-Wen,Luo.Juristic-person director of Microbio Co.,Ltd.
(5)Director:Jing-Quan,Lu.Juristic-person director of Microbio Co.,Ltd.
(6)Director:Yitai Investment Co., Ltd
(7)Director:Zhi-Quan,Chen.Juristic-person director of Yitai Investment Co.,
Ltd
3.Items of competitive conduct in which the officer is
permitted to engage:
(1)Director:Microbio Co.,Ltd.
   Diamond Biofund Inc./Chairman
   Microsoy International Inc./Chairman and Director
   Sun Biofund Inc./Chairman
   Oneness Biotech Co., Ltd./Director
   Microbio (Shanghai) Co., Ltd./Chairman and Director
(2)Director:Shan Ney, Huang.Juristic-person director of Microbio Co.,Ltd.
   Harmony Organic Agriculture Foundation/Chairman
   Oneness Biotech Co., Ltd./Chairman and President
   Microbio Co.,Ltd./Juristic-person chairman of Microbio Co.,Ltd. and
   President
(3)Director:Xiang-Chun,Weng.
   Deeksha Organic Enterprise Co., Ltd./Director
   Xiangchun Biomass Business Co., Ltd./Director
   Prosperity Co., Ltd./Director
(4)Director:Chi-Wen,Luo.Juristic-person director of Microbio Co.,Ltd.
   Cotton Field Organic Farm Inc./Juristic-person Director
(5)Director:Jing-Quan,Lu.Juristic-person director of Microbio Co.,Ltd.
   Harmony Organic Agriculture Foundation/Director
(6)Director:Yitai Investment Co., Ltd
   OBI Pharma, Inc./Director
   CHO Pharma, Inc./Director
(7)Director:Zhi-Quan,Chen.Juristic-person director of Yitai Investment Co.,
   Ltd
   Amaran Biotechnology Inc./Juristic-person Director
   Mithra Biotechnology Inc./Juristic-person Director
   Mass Solutions Technology/Juristic-person Director
   Tanvex Biologics, Inc./Juristic-person Director
   Tanvex BioPharma,Inc./Juristic-person Director
   CHO Pharma, Inc./Juristic-person Director
   TaiMed Biologics Inc./Juristic-person Director
   Mithra Chemical Analysis Laboratory Inc./Juristic-person Director
   RenBio, Inc./Juristic-person Director
   OBI Pharma, Inc./Juristic-person Director
   Miho International Cosmetic Co., Ltd./Juristic-person Director
   RenBio Holdings/Juristic-person Director
   Theragent, Inc./Juristic-person Director
   Delos Capital Holdings Limited/Juristic-person Director
   Gogoro Inc./Juristic-person Director
   Do-Intelligent Consulting Inc./Juristic-person Director
4.Period of permission to engage in the competitive conduct:
Within period serving as a director in the Company.
5.Circumstances of the resolution (please describe the
results of voting in accordance with Article 209 of the
Company Act):
Unanimous approval from all presented shareholders upon chairman's inquiry.
6.If the permitted competitive conduct belongs to the
operator of a mainland China enterprise, the name and
title of the directors (if it is not the operator of
a mainland China enterprise, please enter “N/A” below):
Microbio Co.,Ltd./Director
7.Company name of the mainland China enterprise and the
officer’s position in the enterprise:
Microbio (Shanghai) Co., Ltd./Chairman and Director
8.Address of the mainland China enterprise:
1188 Guangxing Road, Songjiang District, Shanghai
9.Operations of the mainland China enterprise:
Production and marketing of health capsules and tablets, processing of
Chinese herbal medicine,its extraction and Traditional Chinese Medicine
patent prescription and new drug research and development, etc.
10.Impact on the company’s finance and business:None.
11.If the directors have invested in the mainland China
enterprise, the monetary amount of the investment and
their shareholding ratio:
The direct and indirect investment amount from Microbio Co., Ltd. is
US 16,386,264 and the shareholding is 58.9%.
12.Any other matters that need to be specified:None.